INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY TRICYCLIC ANTI-DEPRESSANTS AND OTHER DRUGS

被引:76
作者
OTTON, SV
INABA, T
KALOW, W
机构
关键词
D O I
10.1016/0024-3205(83)90315-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:795 / 800
页数:6
相关论文
共 20 条
[11]   E-10-HYDROXYLATION AND Z-10-HYDROXYLATION OF NORTRIPTYLINE - RELATIONSHIP TO POLYMORPHIC DEBRISOQUINE HYDROXYLATION [J].
MELLSTROM, B ;
BERTILSSON, L ;
SAWE, J ;
SCHULZ, HU ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :189-193
[12]  
MELLSTROM B, 1981, DRUG METAB DISPOS, V9, P565
[13]  
MITCHELL JR, 1970, J PHARMACOL EXP THER, V172, P108
[14]   INVITRO METABOLISM OF SPARTEINE BY HUMAN-LIVER - COMPETITIVE-INHIBITION BY DEBRISOQUINE [J].
OTTON, SV ;
INABA, T ;
MAHON, WA ;
KALOW, W .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (01) :102-105
[15]  
REILLY PAJ, 1978, THESIS U TORONTO
[16]   PHARMACOGENETICS OF TOLBUTAMIDE METABOLISM IN HUMANS [J].
SCOTT, J ;
POFFENBARGER, PL .
DIABETES, 1979, 28 (01) :41-51
[17]   POLYMORPHISM OF CARBON OXIDATION OF DRUGS AND CLINICAL IMPLICATIONS [J].
SLOAN, TP ;
MAHGOUB, A ;
LANCASTER, R ;
IDLE, JR ;
SMITH, RL .
BRITISH MEDICAL JOURNAL, 1978, 2 (6138) :655-657
[18]   SPARTEINE METABOLISM IN CANADIAN CAUCASIANS [J].
VINKS, A ;
INABA, T ;
OTTON, SV ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (01) :23-29
[19]  
von Bahr C, 1971, Xenobiotica, V1, P69
[20]   DRUG-METABOLISM IN HUMAN-LIVER INVITRO - ESTABLISHMENT OF A HUMAN-LIVER BANK [J].
VONBAHR, C ;
GROTH, CG ;
JANSSON, H ;
LUNDGREN, G ;
LIND, M ;
GLAUMANN, H .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :711-725